The Definitive Peptide Research Reference Guide — Compound Review

Home Compounds BPC-157 TB-500 CJC-1295 Ipamorelin GLP-1 GHK-Cu Epithalon NAD+ Comparisons BPC-157 vs TB-500 Sermorelin vs Ipamorelin Semaglutide vs Tirzepatide Guides GHK-Cu Guide GHRH Analogues Ipamorelin Guide Semaglutide Dosage BPC-157 Dosage Research Guides Joint Pain Weight Loss Longevity Shop Purgo Labs

For Bodybuilding

Research guide for for bodybuilding — mechanisms, protocols, and independent analysis from Compound Review.

Why CJC-1295 Works for Bodybuilding

CJC-1295 amplifies growth hormone pulsatility by acting as a long-acting GHRH analogue. For body composition goals, elevated GH drives lipolysis (fat oxidation) and supports lean mass preservation during caloric restriction. Unlike exogenous GH, CJC-1295 works through the pituitary's natural release mechanism, preserving feedback regulation and avoiding the supraphysiologic GH levels associated with direct GH injection.

CJC-1295 Bodybuilding Dosage Protocols

Bodybuilding protocols commonly combine CJC-1295 without DAC (100 mcg) with Ipamorelin (100–200 mcg) injected 2–3× daily — before sleep, upon waking, and pre-workout. This combination targets both GHRH and ghrelin receptors, producing a synergistic GH pulse. Cycles of 8–16 weeks are typical, with a 4-week off period. Caloric surplus during bulking phases may blunt GH response due to elevated insulin and IGF-1 feedback.

Expected Body Composition Timeline

Expected body composition changes from CJC-1295 protocols are gradual — researchers typically report improved body fat percentage and lean mass ratios over 8–12 weeks rather than acute mass gains. The mechanism is permissive rather than anabolic: it creates a hormonal environment favorable to muscle protein synthesis and fat oxidation rather than directly driving hypertrophy.